Catequentinib hydrochloride clinical trials
Also written Anlotinib Hydrochloride and AL3818.
A product of Anlotinib; its studies count on that page too.
How each study uses catequentinib hydrochloride is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the catequentinib hydrochloride studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
94 studies that test it; most in 2019 (22)
| Year | Studies |
|---|---|
| 2018 | 8 |
| 2019 | 22 |
| 2020 | 17 |
| 2021 | 18 |
| 2022 | 8 |
| 2023 | 9 |
| 2024 | 5 |
| 2025 | 1 |
| 2026 | 6 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 20 · Other 74
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (20) · Sun Yat-sen University (6) · Peking Union Medical College Hospital (4) · Zhejiang Cancer Hospital (4) · The First Affiliated Hospital with Nanjing Medical University (3) · Henan Cancer Hospital (3) · Fudan University (2) · Cancer Institute and Hospital, Chinese Academy of Medical Sciences (2)
Often tested with
Tested in the same studies.
Penpulimab (11) · Benmelstobart (11) · Toripalimab (3) · Tislelizumab (2) · Sintilimab (2) · Aflutinib (1) · Partial Nephrectomy (1) · Epirubicin (1)
Related medicines
As reviewed, each with the page that says it.
- A salt or form of Anlotinib source
- One of Protein Kinase Inhibitors source
- One of Tyrosine kinase inhibitors (TKIs) source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 5, 1 in phase 3
Studies that test catequentinib hydrochloride, phase 3 first.
- Dec 2026A Phase III Clinical Trial of AK105 Injection Combined With Anlotinib Hydrochloride Capsules Versus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC)Phase 3 · Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Dec 2026Newly Diagnosed GlioblastomaPhase 2 · Sun Yat-sen University
- Dec 2026SRT Combined With Anlotinib for the Treatment of Brain Metastases From Non-small Cell Lung CancerNot applicable · The First People's Hospital of Lianyungang
- Jan 2027A Study of Bemotuzumab Plus Chemotherapy and Anlotinib Induction Followed by Bemotuzumab, Anlotinib and Consolidative Thoracic Radiotherapy in Extensive-Stage Small Cell Lung CancerPhase 2 · Tianjin Medical University Cancer Institute and Hospital
- Jun 2027Study of Anlotinib in Patients With Advanced Medullary Thyroid CarcinomaPhase 4 · Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Studies
Open first, then newest update. How each study uses catequentinib hydrochloride is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 94
- Clinical Trials of Benmelstobart Injection Combined With Anlotinib Hydrochloride Capsules in the Treatment of Advanced or Unresectable Alveolar Soft Part SarcomaRecruitingPhase 2Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT07548177Written as Benmelstobart injection combined with Anlotinib hydrochloride capsule
- Neoadjuvant Anlotinib and Epirubicin for T4 Sinonasal Adenoid Cystic CarcinomaRecruitingPhase 2Eye & ENT Hospital of Fudan UniversityNCT07616141Written as Anlotinib Hydrochloride
- Risk-Adapted Anlotinib and PD-L1 for Locoregionally Advanced Nasopharyngeal CarcinomaNot yet recruitingPhase 2Sun Yat-sen UniversityNCT07904819Written as Anlotinib Hydrochloride Capsules
- A Study of Bemotuzumab Plus Chemotherapy and Anlotinib Induction Followed by Bemotuzumab, Anlotinib and Consolidative Thoracic Radiotherapy in Extensive-Stage Small Cell Lung CancerRecruitingPhase 2Tianjin Medical University Cancer Institute and HospitalNCT07358676Written as Bemotuzumab + Anlotinib + Chemotherapy + Radiotherapy
- Anlotinib + Benmelstobart vs Surgery for Patients With Localized Renal Cell Carcinoma Scheduled to Undergo Partial NephrectomyNot yet recruitingPhase 2Tianjin Medical University Cancer Institute and HospitalNCT07627464Written as Anlotinib hydrochloride + Benmelstobart + Partial nephrectomy
- Preoperative IMRT With Anlotinib and Penpulimab for Localized Sarcoma (SPARE-01)RecruitingPhase 2Cancer Institute and Hospital, Chinese Academy of Medical SciencesNCT05167994Written as Anlotinib hydrochloride
- Anlotinib Plus Immunotherapy and Chemoradiotherapy for High-Risk Nasopharyngeal CarcinomaNot yet recruitingPhase 3Sun Yat-sen UniversityNCT07385079Written as Anlotinib Hydrochloride Capsules
- Radiation Therapy Followed by Tislelizumab and Anlotinib Aeoadjuvant/Adjuvant Therapy for Stage II-IIIA NSCLCRecruitingPhase 2Ji YonglingNCT06379087Written as Anlotinib Hydrochloride Capsule
- Exploratory Study on the Safety and Efficacy of Disitamab Vedotin in Combination with Anlotinib Hydrochloride for the Treatment of HER-2-expressing Recurrent Platinum-resistant Ovarian Cancer.RecruitingEarly Phase 1Second Xiangya Hospital of Central South UniversityNCT06660511Written as Disitamab Vedotin in Combination With Anlotinib Hydrochloride
- Anlotinib Hydrochloride Capsules Combined With TQB2450 in the Treatment of Endometrial CancerNot yet recruitingPhase 3Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT06475599Written as Anlotinib hydrochloride capsule + TQB2450 injection
- SRT Combined With Anlotinib for the Treatment of Brain Metastases From Non-small Cell Lung CancerRecruitingNot applicableThe First People's Hospital of LianyungangNCT06476093Written as Anlotinib hydrochloride
- A-RGEMOX in the Treatment of Early Relapsed/Refractory DLBCLRecruitingPhase 2Zhejiang Cancer HospitalNCT06086197Written as Anlotinib hydrochloride, Rituximab, gemcitabine, oxaliplatin
- XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction AdenocarcinomaRecruitingPhase 2The First Affiliated Hospital with Nanjing Medical UniversityNCT05494060Written as Anlotinib hydrochloride capsule
- Study of Anlotinib in Patients With Radioiodine Refractory Differentiated Thyroid CancerNot yet recruitingNot applicablePeking Union Medical College HospitalNCT06062563Written as Anlotinib Hydrochloride Capsule and Penpulimab
- Neoadjuvant Therapy of Anlotinib Combined With Toripalimab and Chemotherapy for Resectable Esophageal CarcinomaNot yet recruitingPhase 2Nanfang Hospital, Southern Medical UniversityNCT05996484Written as Anlotinib hydrochloride
- Study of Anlotinib in Patients With Advanced Medullary Thyroid CarcinomaRecruitingPhase 4Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT05830500Written as Anlotinib Hydrochloride Capsule
- A Phase Ib Study of TQB2450 Combined With Anlotinib in Patients With Limited Stage Small Cell Lung Cancer After First-line Radiotherapy and ChemotherapyRecruitingPhase 1Jinming YuNCT05942508Written as TQB2450 Injection + Anlotinib Hydrochloride Capsules
- A Clinical Study of TQB2450 Injection Combined With Chemotherapy or Anlotinib Hydrochloride Capsule in the Treatment of Non Small Cell Lung CancerRecruitingPhase 2Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT05913089Written as TQB2450 injection + Anlotinib Hydrochloride Capsule
- Anlotinib Hydrochloride Capsules Combined With Penpulimab Injection for the Treatment of Hepatocellular Carcinoma at High Risk of Recurrence.RecruitingPhase 3Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT05862337Written as Anlotinib hydrochloride capsules, Penpulimab injection
- Interferon-α1b Combined With Toripalimab and Anlotinib Hydrochloride in Advanced Unresectable MelanomaNot yet recruitingPhase 1/2Xijing HospitalNCT05539118Written as Anlotinib hydrochloride
See all 94 studies that test catequentinib hydrochloride →
Given beside what is tested · 13 — catequentinib hydrochloride is usual care or a partner of the new treatment
- Clinical Trial Comparing TQB2868 Injection Combined With Anlotinib Hydrochloride Capsules With Placebo Combined With Chemotherapy as First-line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)RecruitingPhase 3Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.NCT07165951Written as Anlotinib Hydrochloride Capsules
- A Clinical Study of TQB2618 Injection Monotherapy and Combination Regimen (With Penpulimab Injection ±Anlotinib Hydrochloride Capsules) in the Four or Later Lines of Treatment of Advanced Colorectal Cancer.RecruitingPhase 1Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT06010901Written as Anlotinib hydrochloride capsules
- A Study of Anlotinib Combined With or Without PD-1 Antibody on Unresectable High-grade ChondrosarcomaRecruitingPhase 2Second Affiliated Hospital, School of Medicine, Zhejiang UniversityNCT05193188Written as Anlotinib hydrochloride
- TQB2450 Injection Combined With Chemotherapy Followed by Sequential Combination With Anlotinib Hydrochloride Capsule for First-line Treatment of Advanced Squamous Non-small Cell Lung Cancer.Not yet recruitingPhase 3Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT05718167Written as Anlotinib hydrochloride capsule
- Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma PatientsRecruitingPhase 2Jiangxi Provincial Cancer HospitalNCT05252078Written as Anlotinib hydrochloride
- A Study of Penpulimab Combination Therapy in Patients With Advanced Nasopharyngeal CarcinomaCompletedPhase 2AkesoNCT04736810Written as Anlotinib hydrochloride
- A Study of the Combination of Anti-PD-1 AK105 and Anlotinib in First-line Hepatocellular Carcinoma (HCC)CompletedPhase 2AkesoNCT04172571Written as Anlotinib Hydrochloride
- A Clinical Trial to Evaluate Tolerability and Security of TQB2858 Injection in Subjects With Advanced Pancreatic CarcinomaTerminatedPhase 1Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.NCT05193604Written as Anlotinib Hydrochloride Capsule
- AK105 Plus Anlotinib Hydrochloride Combined With Albumin Paclitaxel as a First-line Therapy in Patients With Advanced Triple-negative Breast CancerStatus unknownPhase 2Liaoning Cancer Hospital & InstituteNCT05244993Written as Anlotinib hydrochloride
- A Clinical Trial to Evaluate the Efficacy and Safety of Anotinib Hydrochloride Capsule Combined With Epirubicin Hydrochloride Versus Placebo Combined With Epirubicin Hydrochloride in First-line Treatment of Advanced Soft Tissue SarcomaStatus unknownPhase 3Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT05121350Written as Anlotinib hydrochloride capsule
- To Evaluate the Safety and Efficacy of TQB2858 Injection to the Subjects With Recurrent/Metastatic Nasopharyngeal CancerStatus unknownPhase 1/2Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT05198531Written as Anlotinib Hydrochloride Capsule
- Novel Treatment of Advanced Hepatocellular CarcinomaStatus unknownPhase 3The First Affiliated Hospital of Zhengzhou UniversityNCT03950518Written as Anlotinib Hydrochloride Capsules
- Treatment of Advanced Intrahepatic CholangiocarcinomaStatus unknownPhase 3The First Affiliated Hospital of Zhengzhou UniversityNCT03940378Written as Anlotinib Hydrochloride Capsules
What changed recently
From the registry's own updates since Oct 18, 2026.
Started recruiting1
- Neoadjuvant Anlotinib and Epirubicin for T4 Sinonasal Adenoid Cystic CarcinomaNov 3, 2026NCT07616141
Newly registered1
- Risk-Adapted Anlotinib and PD-L1 for Locoregionally Advanced Nasopharyngeal CarcinomaOct 29, 2026NCT07904819
Codes
What other systems call catequentinib hydrochloride · ClinicalTrials.gg INT015954
- UNII (FDA) A3749M6582CATEQUENTINIB HYDROCHLORIDEOne source FDA
- NCI Thesaurus C106428Catequentinib HydrochlorideOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | A3749M6582 | CATEQUENTINIB HYDROCHLORIDE | One source FDA |
| NCI Thesaurus | C106428 | Catequentinib Hydrochloride | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.